Promacta
| Promacta | |
|---|---|
| Term | Promacta |
| Short definition | Promacta - (pronounced) (proh-MAK-tuh) drug used to treat thrombocytopenia (low blood platelet counts) in adults and children with chronic immune thrombocytopenic purpura that has not improved with other treatments. Promacta is also used to treat severe aplastic anemia. |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
Promacta - (pronounced) (proh-MAK-tuh) drug used to treat thrombocytopenia (low blood platelet counts) in adults and children with chronic immune thrombocytopenic purpura that has not improved with other treatments. Promacta is also used to treat severe aplastic anemia. It is also being studied in the treatment of other diseases and cancers. Promacta attaches to the thrombopoietin receptor, causing the bone marrow to make more platelets. It is a type of thrombopoietin receptor agonist. Also called eltrombopag olamine
External links
- Medical encyclopedia article on Promacta
- Wikipedia's article - Promacta
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski